Cargando…

Blocking siglec-10(hi) tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma

BACKGROUND: Tumor-associated macrophages (TAMs) promote key processes in the modulation of tumor microenvironment (TME). However, the clinical significance of heterogeneous subpopulations of TAMs in hepatocellular carcinoma (HCC) remains unknown. METHODS: HCC tissues from Zhongshan Hospital and data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Nan, Zhu, Xiaodong, Li, Kangshuai, Chen, Yifan, Liu, Xuefeng, Xu, Bin, Lei, Ming, Xu, Jiejie, Sun, Hui-Chuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191104/ https://www.ncbi.nlm.nih.gov/pubmed/34112250 http://dx.doi.org/10.1186/s40164-021-00230-5

Ejemplares similares

Normalization cancer immunotherapy: blocking Siglec-15!
por: Cao, Guangchao, et al.
Publicado: (2019)

CD24 signalling through macrophage Siglec-10 is a new target for cancer immunotherapy
por: Barkal, Amira A, et al.
Publicado: (2019)

Development of Siglec-9 Blocking Antibody to Enhance Anti-Tumor Immunity
por: Choi, Hyeree, et al.
Publicado: (2021)

Nanoparticles (NPs)-mediated Siglec15 silencing and macrophage repolarization for enhanced cancer immunotherapy
por: Liu, Xiaodi, et al.
Publicado: (2023)

Siglec Signaling in the Tumor Microenvironment
por: van Houtum, Eline J. H., et al.
Publicado: (2021)

Siglec15 is a prognostic indicator and a potential tumor-related macrophage regulator that is involved in the suppressive immunomicroenvironment in gliomas
por: Wang, Jinchao, et al.
Publicado: (2023)

Molecular cloning of porcine Siglec-3, Siglec-5 and Siglec-10, and identification of Siglec-10 as an alternative receptor for porcine reproductive and respiratory syndrome virus (PRRSV)
por: Xie, Jiexiong, et al.
Publicado: (2017)

Induction of Siglec-F(hi)CD101(hi) eosinophils in the lungs following murine hookworm Nippostrongylus brasiliensis infection
por: Chetty, Alisha, et al.
Publicado: (2023)

Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10
por: Yin, Shan-Shan, et al.
Publicado: (2020)

Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
por: Rodriguez, Ernesto, et al.
Publicado: (2021)

Targeting tumor-associated macrophages to synergize tumor immunotherapy
por: Xiang, Xiaonan, et al.
Publicado: (2021)

Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy
por: Xu, Shumin, et al.
Publicado: (2023)

The intriguing roles of Siglec family members in the tumor microenvironment
por: Jiang, Kui-Ying, et al.
Publicado: (2022)

Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy
por: Zheng, Hongyu, et al.
Publicado: (2023)

Siglec10—An immunosuppressor and negative predictor of survival prognosis in gliomas
por: Wang, Hesong, et al.
Publicado: (2022)

Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
por: Wang, Jun, et al.
Publicado: (2019)

Identification of a Siglec-F+ granulocyte-macrophage progenitor
por: Bolden, Jessica E., et al.
Publicado: (2018)

Sialic Acids on Tumor Cells Modulate IgA Therapy by Neutrophils via Inhibitory Receptors Siglec-7 and Siglec-9
por: Chan, Chilam, et al.
Publicado: (2023)

Siglec-15 Promotes Tumor Progression in Osteosarcoma via DUSP1/MAPK Pathway
por: Fan, Meng-ke, et al.
Publicado: (2021)

Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy
por: Li, Guan-Zhang, et al.
Publicado: (2019)

Unveiling Molecular Recognition of Sialoglycans by Human Siglec-10
por: Forgione, Rosa Ester, et al.
Publicado: (2020)

Unveiling Molecular Recognition of Sialoglycans by Human Siglec-10
por: Forgione, Rosa Ester, et al.
Publicado: (2020)

Tumor Derived SIGLEC Family Genes May Play Roles in Tumor Genesis, Progression, and Immune Microenvironment Regulation
por: Chen, Zheng, et al.
Publicado: (2020)

Tumor-associated macrophage-related strategies for glioma immunotherapy
por: Tang, Fansong, et al.
Publicado: (2023)

Targeting myeloid checkpoint Siglec-10 reactivates antitumor immunity and improves anti-programmed cell death 1 efficacy in gastric cancer
por: Lv, Kunpeng, et al.
Publicado: (2023)

High affinity monoclonal antibody targeting Siglec-15 for cancer immunotherapy
por: He, Fei, et al.
Publicado: (2021)

Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy
por: Yu, Yingyan, et al.
Publicado: (2023)

Immunotherapy Targeting Tumor-Associated Macrophages
por: Liu, Yafei, et al.
Publicado: (2020)

Discovery of a novel dual-targeting D-peptide to block CD24/Siglec-10 and PD-1/PD-L1 interaction and synergize with radiotherapy for cancer immunotherapy
por: Shen, Wenhui, et al.
Publicado: (2023)

Siglec-9(+) tumor-associated macrophages delineate an immunosuppressive subset with therapeutic vulnerability in patients with high-grade serous ovarian cancer
por: Wang, Yiying, et al.
Publicado: (2023)

Siglec Ligands
por: Gonzalez-Gil, Anabel, et al.
Publicado: (2021)

Multi-omics analysis of Siglec family genes in cutaneous melanoma
por: Li, Kezhu, et al.
Publicado: (2023)

IMM47, a humanized monoclonal antibody that targets CD24, exhibits exceptional anti-tumor efficacy by blocking the CD24/Siglec-10 interaction and can be used as monotherapy or in combination with anti-PD1 antibodies for cancer immunotherapy
por: Li, Song, et al.
Publicado: (2023)

Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer
por: Xu, Yijia, et al.
Publicado: (2022)

Tumor Microenvironment in Hepatocellular Carcinoma: Key Players for Immunotherapy
por: Feng, Hai, et al.
Publicado: (2022)

Transcriptional Regulation of Siglec-15 by ETS-1 and ETS-2 in Hepatocellular Carcinoma Cells
por: Sheng, Kaiqin, et al.
Publicado: (2023)

MUC1 modulates the tumor immune microenvironment through the engagement of Siglec-9
por: Beatson, Richard, et al.
Publicado: (2016)

Siglec-15 Regulates the Inflammatory Response and Polarization of Tumor-Associated Macrophages in Pancreatic Cancer by Inhibiting the cGAS-STING Signaling Pathway
por: Li, HuaGen, et al.
Publicado: (2022)

LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated macrophages induces radioresistance and the formation of immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma
por: Zhao, Fen, et al.
Publicado: (2023)

Coevolution of Siglec-11 and Siglec-16 via gene conversion in primates
por: Hayakawa, Toshiyuki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eunl78u5rnop80l98c292digio